Advertisement

Topics

Selexis SA and International AIDS Vaccine Initiative (IAVI) Company Profile

06:43 EDT 15th October 2018 | BioPortfolio


News Articles [2258 Associated News Articles listed on BioPortfolio]

IAVI starts Phase l trial of eOD-GT8 60mer for HIV

International AIDS Vaccine Initiative (IAVI) has commenced the Phase I IAVI G001 clinical trial to evaluate safety and immunogenicity of...Read More... The post IAVI starts Phase l trial of eOD-GT8 60...

IAVI, Selexis SA and Collaborators Publish Study Highlighting Improved Approach for Generating Complex Proteins Required for Producing HIV Vaccines

Paper in Frontiers in Immunology Describes Trimer Design and Development of Production CHO Cell Lines That Generate Properly Folded HIV-1 Env Trimers to Support Goal of Developi...

[Comment] A new step towards an HIV/AIDS vaccine

A preventive vaccine is an essential part of the strategy to eradicate the HIV pandemic.1 Although the search for an AIDS vaccine has led to many scientific advances, a vaccine remains out of reach. M...

International AIDS Vaccine Initiative Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23042018] Prices from USD $250

SummaryInternational AIDS Vaccine Initiative IAVI is a notforprofit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, di...

International AIDS Vaccine Initiative Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryInternational AIDS Vaccine Initiative IAVI is a notforprofit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, di...

We are thrilled to share the exciting data about our TB candidate vaccine at #IDWeek2018 @IAVI #endTB https://gsk.to/2PaFStr 

We are thrilled to share the exciting data about our TB candidate vaccine at #IDWeek2018 @IAVI #endTB https://gsk.to/2PaFStr 

Selexis and Symphogen expand partnership to progress two mAbs

Selexis and Symphogen have announced that the latter has submitted INDs for clinical programmes to progress two mAbs using Selexisâ platform.

AIDS vaccine offers hope in early trial – The Hindu

The HinduAIDS vaccine offers hope in early trialThe HinduThe near 40-year quest for an AIDS vaccine received a hopeful boost on Saturday when scientists announced that a trial drug triggered an immune...

PubMed Articles [2278 Associated PubMed Articles listed on BioPortfolio]

Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India.

A Phase I HIV-1 vaccine trial sponsored by the International AIDS Vaccine Initiative (IAVI) was conducted in India in 2009 to test a subtype C prophylactic vaccine in a prime-boost regimen comprising ...

Detection of rotavirus before and after monovalent rotavirus vaccine introduction and vaccine effectiveness among children in mainland Tanzania.

Monovalent rotavirus vaccine (RV1) was introduced in Tanzania in January 2013 under the Reach Every Child initiative, to be given at ages 6 and 10 weeks. We used the sentinel hospital rotavirus surv...

Monkey Models and HIV Vaccine Research.

Since the discovery of acquired immunodeficiency syndrome (AIDS) in 1981, it has been extremely difficult to develop an effective vaccine or a therapeutic cure despite over 36 years of global efforts...

Prospects for a vaccine to prevent HIV-related tuberculosis.

To outline the need for a new tuberculosis (TB) vaccine; challenges for induction of vaccine-mediated protection in HIV-infected persons; and recent advances in clinical development.

Multimonth Prescription of Antiretroviral Therapy Among Children and Adolescents: Experiences From the Baylor International Pediatric AIDS Initiative in 6 African Countries: Erratum.

Clinical Trials [5526 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Safety of a Polyvalent Virus in Healthy Adults

This is a research study to evaluate the safety of a vaccine to protect people from HIV infection. Human Immunodeficiency Virus (HIV) is the cause of AIDS (Acquired Immune Deficiency Syndr...

Development of a New HIV Vaccine

The purpose of the study is to determine the safety of a new HIV vaccine and to evaluate the immune response to the vaccine. Only some HIV genes are used to make the vaccine and therefore...

Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention

The Mother-Daughter Initiative (MDI) will test the feasibility and acceptability of a strategy to deliver comprehensive cervical cancer prevention services in Thailand and the Philippines ...

Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)

This trial studies the safety and immunogenicity of a HIV clade B'/C DNA vaccine followed by recombinant vaccinia virus rTV boost in HIV-uninfected healthy volunteers at low or high risk o...

Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults

This study will evaluate the safety of and immune response to a new HIV vaccine. The vaccine in this trial uses pieces of HIV DNA and HIV proteins. The vaccine itself cannot cause HIV in...

Companies [2048 Associated Companies listed on BioPortfolio]

Selexis SA and International AIDS Vaccine Initiative (IAVI)

IAVI

The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV ...

GlycoMimetics, Inc. and International AIDS Vaccine Initiative and Glycosensors and Diagnostics, LLC

IAVI is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. Found...

The International AIDS Vaccine Initiative (IAVI)

International AIDS Vaccine Initiative

More Information about "Selexis SA and International AIDS Vaccine Initiative (IAVI)" on BioPortfolio

We have published hundreds of Selexis SA and International AIDS Vaccine Initiative (IAVI) news stories on BioPortfolio along with dozens of Selexis SA and International AIDS Vaccine Initiative (IAVI) Clinical Trials and PubMed Articles about Selexis SA and International AIDS Vaccine Initiative (IAVI) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Selexis SA and International AIDS Vaccine Initiative (IAVI) Companies in our database. You can also find out about relevant Selexis SA and International AIDS Vaccine Initiative (IAVI) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record